IPW
RPRX icon

Inlet Private Wealth’s Royalty Pharma RPRX Stock Holding History

Inlet Private Wealth’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Sell
211,150
-4,850
-2% -$252K 2.88% 6
2026
Q1 		$10.4M Sell
216,000
-9,800
-4% -$429K 2.65% 7
2025
Q4 		$8.72M Sell
225,800
-9,350
-4% -$357K 2.02% 11
2025
Q3 		$8.3M Buy
235,150
+310
+0.1% +$11.2K 1.87% 15
2025
Q2 		$8.46M Buy
234,840
+100
+0% +$3.31K 2.08% 11
2025
Q1 		$7.31M Sell
234,740
-2,000
-0.8% -$63.4K 1.9% 13
2024
Q4 		$6.04M Buy
236,740
+48,280
+26% +$1.28M 1.6% 17
2024
Q3 		$5.33M Buy
+188,460
New +$5.22M 1.35% 25

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Inlet Private Wealth's RPRX Position: Q2 2026 in Review

Inlet Private Wealth reduced its Royalty Pharma (RPRX) stake by 2.2% in Q2 2026, selling an estimated $252K and leaving 211,150 shares worth $11.8M. The position accounts for 2.88% of the portfolio, ranked #6.

Inlet Private Wealth first reported a position in RPRX in Q3 2024 and has held it in 8 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Inlet Private Wealth held 211,150 shares of Royalty Pharma worth $11.8M as of Q2 2026.
  • Inlet Private Wealth sold 4,850 Royalty Pharma shares in Q2 2026, an estimated $252K.
  • Royalty Pharma made up 2.88% of Inlet Private Wealth's portfolio in Q2 2026, its #6 holding.
  • Inlet Private Wealth first reported a position in Royalty Pharma in Q3 2024 and has held it in 8 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Inlet Private Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.